AMG 386 Phase 2 Open-Label Renal Cell Carcinoma (RCC) Study 1st Line or After Cytokine Failure in Combination With Sunitinib

Clinical trial NCT00853372 · COMPLETED

Trial details

NCT number: NCT00853372
Sponsor: Amgen
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Advanced Renal Cell Carcinoma

Start date: 2009-05-28
Primary completion: 2011-08-08
Enrollment: 85

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.